The brazil customer reported "residue on some slides".Fse (field service engineer) inspected the instrument and observed obstruction of the aspiration and dispensing check valve.Fse replaced aspiration and dispense check valve which resolved this malfunction.The customer was able to complete staining.The instrument is fully operational, within specification, and ready for use.Diagnostics were not altered.There was no direct or indirect patient harm or user harm reported.
|
Please consider this letter as a notification on agilent's position to cease reporting autostainer aspiration/dispense complaints that do not satisfy the criteria of 21 cfr part 803.Below you will find the summary of data and our rationale for our decision to cease reporting after submitting mdr's for the past two+ years.In july of 2020 agilent had an agreement with the fda to file mdrs for autostainer complaints with any potential risk for false results due to liquid aspiration or dispense part failures that could cause leakage of reagents.This agreement was put into place due to recall z-2074-2020 which was related to autostainers sold with a missing syringe tray.The recall was closed in may 2022.Since july of 2020 agilent has reported all complaints associated with the probe, syringe and stopcock, and aspiration/dispense check valve with associated tubing, as per the fda's request.There have been 771 complaints reported all without adverse events or false results.The last reported malfunction with no adverse event was mdr # 3003423869-2023-00083.The likelihood of one of the above failure modes leading to an adverse event is deemed as remote since we have not received any incident complaints since initiating this reporting request.By reporting these complaints to you over the past 2+ years, i hope you will see that agilent technologies inc., has made great improvements to the complaint and vigilance processes.We will now cease reporting complaints that do not satisfy the criteria of 21 cfr part 803 for the autostainer.
|